(Q38328870)

2 September 2017

1 reference

title

The cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time (English)

1 reference

2 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Michele W Tang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Karl V Clemons

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

David A Stevens

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

23 January 2015

1 reference

Critical Reviews in Microbiology

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

634-642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Comparison of four assays for the detection of cryptococcal antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Prognostic factors in cryptococcal meningitis. A study in 111 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

CrAg lateral flow assay for cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Epidemiology of cryptococcal meningitis in the US: 1997-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells/mcL

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2014.982509

10.3109/1040841X.2014.982509

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25612826%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference